About us Contacts Drug interactions: 390 212
Drug search by name

Carboplatin and Furosemide Tablets

Determining the interaction of Carboplatin and Furosemide Tablets and the possibility of their joint administration.

Check result:
Carboplatin <> Furosemide Tablets
Relevance: 18.11.2023 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Using CARBOplatin together with furosemide may increase the risk of kidney damage and hearing loss. These effects may be more likely to occur in older adults or those with preexisting kidney problems or dehydration, or when high dosages of one or both medications are used. Talk to your doctor if you have any questions or concerns. Your doctor may already be aware of the risks, but has determined that this is the best course of treatment for you and has taken appropriate precautions and is monitoring you closely for any potential complications. Keep yourself hydrated by drinking plenty of fluids unless otherwise directed. Let your doctor know if you experience ringing in the ears or hearing loss, or signs and symptoms that may suggest kidney damage such as nausea, vomiting, loss of appetite, increased or decreased urination, sudden weight gain or weight loss, fluid retention, swelling, shortness of breath, muscle cramps, tiredness, weakness, dizziness, confusion, and irregular heart rhythm. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

MONITOR: The concomitant use of loop diuretics with carboplatin may increase the risk of ototoxicity. Loop diuretics, especially ethacrynic acid and high doses of furosemide, and platinum compounds have been individually associated with ototoxicity. Carboplatin is generally considered to be less neurotoxic and ototoxic than cisplatin; however, hearing loss has been reported when pediatric patients received high doses of carboplatin with other ototoxic agents.

MANAGEMENT: It is recommended to regularly monitor auditory function if concomitant use is necessary. Patients should be advised to promptly notify their physician if they experience hearing loss or tinnitus.

References
  • Langer T, am Zehnhoff-Dinnesen A, Radtke S, Meitert J, Zolk O "Understanding platinum-induced ototoxicity." Trends Pharmacol Sci 34 (2013): 458-69
  • "Product Information. Edecrin (ethacrynic acid)." Merck & Co, Inc, West Point, PA.
  • Cerner Multum, Inc. "Australian Product Information." O 0
  • Cerner Multum, Inc. "UK Summary of Product Characteristics." O 0
  • Parsons SK, Neault MW, Lehmann, et al "Severe ototoxicity following carboplatin-containing conditioning regimen for autologous marrow transplantation for neuroblastoma." Bone Marrow Transplant 22 (1998): 669-74
  • "Product Information. Paraplatin (carboplatin)." Bristol-Myers Squibb, Princeton, NJ.
  • Brock PR, Knight KR, Freyer DR, et al. "Platinum-induced ototoxicity in children: a consensus review on mechanisms, predisposition, and protection, including a new International Society of Pediatric Oncology Boston ototoxicity scale." J Clin Oncol 30 (2012): 2408-17
Carboplatin

Generic Name: carboplatin

Brand name: Paraplatin, CARBOplatin Novaplus

Synonyms: CARBOplatin

Furosemide Tablets

Generic Name: furosemide

Brand name: Lasix, Diaqua-2, Lo-Aqua

Synonyms: Furosemide

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle
Disease interaction